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Ventilator-associated pneumonia (VAP) is relatively common in mechanically-ventilated children, but there is a wide
variation in reported VAP rates, depending on settings and geographical regions. Surveillance definitions in children
are challenging. Although these are provided by the German nosocomial infection surveillance system and an
independent Dutch group, the combination of clinical and radiologic signs leaves room for interpretation. Of
note, the United States Centers for Disease Prevention and Control guidelines do not offer algorithms for neonates.
Despite the fact that most experts agree on the low sensitivity and specificity of existing definitions, little has changed
over the past years. However, the number of studies reporting on VAP prevention programs has increased in recent
years. Single interventions, such as chlorhexidine mouth wash or stress ulcer prophylaxis, were not effective. Successful
prevention programs combined multiple interventions, such as hand hygiene, glove and gown use for endotracheal
tube manipulation, backrest elevation, oral care with chlorhexidine, stress ulcer prophylaxis, cuff pressure maintenance
where appropriate, use of orogastric tubes, avoidance of gastric overdistension, and elimination of non-essential
tracheal suction. These multimodal strategies have proved to be successful among neonates, infants, and children.
Importantly, they are applicable in high- as well as in low- and middle-income countries. This review provides an
update of VAP incidence rates and summarizes current knowledge on its epidemiology, risk factors, surveillance
definitions, and prevention programs in the pediatric setting.
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Healthcare-associated infections (HAIs) are associated
with morbidity, mortality, and prolonged hospitalization,
and represent a serious threat to patient safety. Hospital-
ized children are a particularly vulnerable population [1].
The incidence of HAI in adult and pediatric intensive
care units (PICUs) is high. This is due to the many inva-
sive procedures and frequent antibiotic use, which put
the patients at risk for infection and promote the emer-
gence of multidrug-resistant organisms [2]. The use of
invasive devices in PICUs, such as central vascular lines
and mechanical ventilation, is similar to adult intensive
care and thus the burden of ventilator-associated pneu-
monia (VAP) and other HAIs is also similar [3]. In this
review, we describe the epidemiology of VAP, summarize* Correspondence: walter.zingg@hcuge.ch
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unless otherwise stated.risk factors, and discuss effective prevention measures in
PICUs and neonatal ICUs (NICUs).Review
Literature search and selection strategy
A Medline search was performed for publications prior
to 1 May 2014 using the following search (MeSH) terms:
“pneumonia, ventilator associated” AND (child* OR neo-
nat* OR infant* OR pediatr* OR paediatr*) and also
pneumonia AND (nosocomial OR “healthcare-associ-
ated” OR “healthcare associated” OR “health care associ-
ated”) AND (ventilat* OR intubat* OR respirat*) AND
(child* OR neonat* OR infant* OR pediatr* OR paediatr*).
Cross-referencing from retrieved publications was used to
complete the search, including manual searches of cited
references and relevant abstracts. Publications were eli-
gible to be analyzed if they addressed VAP in any inpatient
pediatric population. A total of 443 titles and abstracts
were screened; 95 were retained for discussion in this
review.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Case definitions of hospital-acquired pneumonia
in children stratified by different age groups
Neonates Onset >72 h after birth and one of the following
radiologic criteria:
−new or progressive infiltrates
−consolidations
−adhesions or fluid in lobar fissures/pleura
And
Worsening gas exchange (SaO2 ↓; O2 requirement ↑;
Ventilation parameters ↑)
And
Four of the following signs and symptoms:
−fever (>38.0°C), hypothermia (<36.5°C), or
temperature instability
−new onset or increasing bradycardia (<80/min) or
tachycardia (>200/min)
−new onset or increasing tachypnoea (>60/min) or
apnoea (>20 seconds)
−new onset or increasing signs of dyspnoea
(retractions, nasal flaring, grunting)
−increasing production of respiratory secretions and
need for suctioning
−purulent tracheal secretion
−isolation of a pathogen in respiratory secretions




One of the following radiologic criteria:





Worsening gas exchange (SaO2 ↓; O2 requirement ↑;
Ventilation parameters ↑)
And
Three of the following signs and symptoms:
−fever (>38.0°C), hypothermia (<36.5°C), or
temperature instability
−leucopenia (<4000 WBC/mm3) or leucocytosis
(≥15,000 WBC/mm3) with left shift (≥10% band
forms)
−new onset of purulent sputum, or change in
character of sputum, or increased respiratory
secretions, or increased suctioning requirements
−apnoea or dyspnoea (tachypnoea, nasal flaring,
retraction of chest wall, grunting)
−wheezing, rales, or rhonchi
−cough
−bradycardia (<100/min) or tachycardia (>170/min)
Table 1 Case definitions of hospital-acquired pneumonia
in children stratified by different age groups (Continued)
Children: 1–16
years
One of the following radiologic criteria:




Three of the following signs and symptoms:
−fever (>38.4°C) or hypothermia (<36.5°C)
−leukopenia (<4000 WBC/mm3) or leucocytosis
(≥15,000 WBC/mm3)
−new onset of purulent sputum or change in
character of sputum or increased respiratory
secretions or increased suctioning requirements
−new onset or worsening cough or dyspnoea,
apnoea, or tachyponea
−rales or bronchial breath sounds
−worsening gas exchange (SaO2 ↓; O2 requirement ↑;
Ventilation parameters ↑)
SaO2: Oxygen saturation; I/T-ratio: immature to total neutrophil ratio; WBC:
white blood cell count; ↑: increase; ↓: decrease.
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A uniform definition of VAP needs to have the capacity
to be relevant for clinical trials, while balancing the risks
of experimental therapy and sampling procedures with
potential benefits for study patients [4]. If the definition
of VAP is already controversial for adults, it is even
more challenging for children, in particular for venti-
lated neonates. The starting point of the recent United
States (US) Centers for Disease Prevention and Control
(CDC) definitions for adults is a ventilator-associated
complication (VAC), which is further narrowed towards
infectious VAC and then towards possible or probable
VAP, according to additional diagnostics [5]. However, It
is not clear whether this algorithm can be applied to
children in different age groups and, thus, the conven-
tional CDC definitions of hospital-acquired pneumonia
for children and neonates remain valid for the time be-
ing [6]. These definitions do not specify between “venti-
lated” or “non-ventilated” and the use of the term “VAP”
depends on the time on ventilation (48 h or longer). The
German national nosocomial infection surveillance system
(Krankenhaus Infektions Surveillance System [KISS]) of-
fers a definition for very low birth weight infants in their
“Neo-KISS” module [7]. A Dutch study group established
their own definition for VAP in neonates, which are more
inclusive than the CDC definitions [8]. Table 1 summa-
rizes the definitions of hospital-acquired pneumonia by
stratifying age groups into neonates, infants (≤1 year), and
children (>1 year to ≤ 16 years). All definitions combine
clinical and radiologic signs. In addition, the CDC and the
European Centre for Disease Prevention and Control
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probable, and possible healthcare-associated pneumonia,
based on microbiologic findings (Table 2) [9]. Clinical and
radiologic findings lack sensitivity and specificity. How-
ever, tracheal aspirate cultures have also low sensitivity
(31-69%) and specificity (55-100%). A positive tracheal
culture alone does not discriminate between bacterial
colonization and respiratory infection. Bronchoalveolar
lavage (BAL) provides better results, but the range of sen-
sitivity (11-90%) and specificity (43-100%) is large.
Clinical criteria
Clinical criteria for healthcare-associated pneumonia in-
clude fever, leukocytosis or leucopoenia, purulent secre-
tions, new or worsening cough, dyspnoea, tachypnoea,
crackles or bronchial breath sounds, and worsening gas
exchange. These criteria are nonspecific and their sensi-
tivity and specificity relative to the underlying pathology
is poor [2]. Clinical findings must be combined with
radiologic and microbiologic findings. In a study of 70
children with VAP, the modified clinical pulmonary in-
fection score (mCPIS) of six or higher had a sensitivity
of 94%, a specificity of 50%, a positive predictive value of
64%, a negative predictive value of 90%, and positive and
likelihood ratios of 1.9 and 0.1, respectively [10].
Radiologic criteria
Radiologic criteria include the presence of new or pro-
gressive pulmonary infiltrates, adhesions or fluid in lobar
fissures/pleura, cavitations, air bronchograms, or pneu-
matoceles on chest x-rays. The presence of air bronch-
ograms has a higher sensitivity (58–83%) than “evolving
infiltrates” (50–78%) [2]. Sequential chest x-rays (days −3,
0, 2, 7) help to confirm healthcare-associated pneumonia
in complex cases, such as children with underlying cardiac
or pulmonary disease. Onset and progression of pneumo-
nia in imaging is fast, but improvement takes time.Table 2 Classification of hospital-acquired pneumonia in child
Definite VAP A child who fulfils the case definitions for hospital-acquir
−same pathogen isolated from bronchial secretions/BAL
−pathogen or virus isolated from lung biopsy, or positive
evidence of pneumonia manifested as abscess formation
−Pathogen or virus isolated from BAL (bacteria ≥104 CFU
microscopic exam, or protected brush with a threshold o
CFU/ml, or positive exams for particular microorganisms
Probable VAP A child who fulfils the case definitions for hospital-acquir
−pathogen isolated from BAL (bacteria <104 CFU/ml)
−pathogen or virus isolated from bronchial secretions, or
aspirate) with a threshold of bacteria ≥106 CFU/ml
Possible VAP A child who fulfils the case definitions for hospital-acquir
specimen culture or no positive microbiology, but has be
BAL: bronchoalveolar lavage; CFU: colony-forming units.Microbiologic criteria
Respiratory cultures are obtained by tracheal aspirates,
bronchoalveolar lavage (BAL), non-bronchoscopic BAL,
or protected brush specimens (PBS) [10]. Thresholds are
summarized in Table 2.Epidemiology
Healthcare-associated pneumonia was the most com-
mon HAI in five studies [11-15], and second only to
bacteremia in another two reports [16,17]. The range of
VAP incidence density rates in both children and neo-
nates is large. Rates as low as 1/1000 ventilator-days and
as high as 63/1000 ventilator-days have been reported
(Table 3). The incidence follows a geographical distribu-
tion and depends on the type of hospital and the country
income level. A surveillance study from the International
Nosocomial Infection Control Consortium (INICC) iden-
tified higher VAP rates in academic compared to non-
academic hospitals [18]. The same study reported higher
rates in lower-middle-income compared to upper-middle-
income countries. Extreme PICU rates have been reported
from India (36.2%) [19] and Egypt (31.8/1000 ventilator-
days) [20]. Surveys in the USA and Germany found con-
sistently lower rates (Table 3) [21-23]. However, high rates
were reported also by high-income countries. A European
multicenter study found that 23.6% of children admitted
to a PICU developed VAP [24]. An Italian study identi-
fied 6.6% children with VAP among 451 on mechanical
ventilation [25], and a mixed PICU in Australia identi-
fied 6.7% children with VAP among 269 on mechanical
ventilation [26].
VAP is also common in the NICU and proportions be-
tween 6.8% and 57.0% of HAIs have been reported
[34,60-66]. A Spanish study identified VAP in 9.1% of
198 neonates on mechanical ventilation [67]. In a
Taiwanese NICU, 11.4% of 528 neonates had one or more
HAIs, with VAP contributing to 18.6% [68]. An INICCren based on microbiological results
ed pneumonia (Table 1) and has one of the following:
and blood
growth in culture of pleural fluid, or histopathologic examination with
, positive culture of lung parenchyma, or fungal hyphae
/ml), or ≥5% of BAL-obtained cells contain intracellular bacteria on direct
f ≥104 CFU/ml, or distal protected aspirate with a threshold of ≥104
(Legionella, Aspergillus, mycobacteria, Mycoplasma, Pneumocystis jirovecii)
ed pneumonia (Table 1) and has one of the following:
quantitative culture of lower respiratory tract specimen (endotracheal
ed pneumonia (Table 1) with non-quantitative lower respiratory tract
en treated for hospital-acquired pneumonia
Table 3 Incidence densities and proportions of ventilator-associated pneumonia in pediatric settings
Region Reference (Author, Country, Year of
publication, Ref No)
Setting Patients VAP* VD* Incidence density (N/1000
ventilation-days)
%**
Middle Afjeh, Iran, 2012 [27] NICU* 281 14 1207 11.6 17.3
East/Persia Almuneef, Saudi Arabia, 2004 [28] PICU* 2361 37 4173 8.9 10.3
Shaath, Saudi Arabia, 2013 [29] Cardiac surgery 1137 9 306 29.4 6.6
South Asia Awasthi, India, 2013 [19] PICU* 2105 38 - - 36.2
East Asia Yuan, China, 2007 [30] NICU* 2259 52 1130 46.0 20.1
Navoa-Ng, Philippines, 2011 [31] PICU* 3252 6 391 0.44 2.4
Navoa-Ng, Philippines, 2011 [31] NICU* 31813 1 2279 12.8 0.06
Xu, China, 2007 [32] NICU* 33942 143 2259 63.3 3.6
Cai, China, 2010 [33] NICU* 31159 38 779 48.8 3.3
Europe Geffers, Germany, 2008 [21] NICU* (<1500 g) 38677 176 64090 2.7 2.0
Leistner, Germany, 2013 [22] NICU* (<1500 g) - 345 158024 2.2 -
Tekin, Turkey, 2013 [34] NICU* 36932 76 11939 6.4 1.1
Yalaz, Turkey, 2012 [35] NICU* 2162 40 2907 13.8 24.7
Patria, Italy, 2013 [25] PICU* 3451 30 - - 6.7
Hentschel, Switzerland, 2005 [36] NICU* 121 1 80 12.5 4.8
Roeleveld, Netherlands, 2011 [37] Cardiac surgery 1125 11 644 17.1 8.8
Gastmeier, Germany, 2002 [38] Burn unit 341 8 145 55.2 19.5
Oezdemir, Turkey, 2011 [39] PICU* 3203 - - 15.7 -
Jordan Garcia, Spain, 2014 [40] PICU* 3300 4 422 9.5 1.3
Turkish Neonatal Society; 2010 [41] NICU* 39359 - - - 1.7
North Edwards, USA, 2008 [23] PICU* - 176 85809 2.1 -
America Edwards, USA, 2008 [23] NICU* - 410 203466 2.0 -
Edwards, USA, 2007 [42] PICU* - 81 32936 2.5 -
Edwards, USA, 2007 [42] NICU* - 121 63075 1.9 -
Hocevar, USA, 2012 [43] NICU* - 701 336527 2.1 -
Stover, USA, 2001 [44] PICU* - - - 3.7 -
Stover, USA, 2001 [44] NICU* - - - 2.5 -
Apisarnthanarak, USA, 2003 [45] NICU* (ELBW) 2211 24 4173 5.8 11.4
Elward, USA, 2002 [46] PICU* 1595 34 2931 11.6 5.1
Weber, USA, 1997 [47] Burn unit 140 7 614 11.4 17.5
Martinez-Aguilar, Mexico, 2001 [48] PICU* - 44 1571 28 -
South Abramczyk, Brazil, 2003 [11] PICU* 3515 40 2120 18.7 7.8
America Pessoa-Silva, Brazil, 2004 [49] NICU* 34878 83 10494 7.9 1.7
Araujo da Silva Brazil, 2012 [50] Homecare 19 23 3394 6.8 -
Casado, Brazil, 2011 [51] PICU* 1366 39 1439 27.1 10.7
Duenas, Argentina, 2011 [52] PICU* 31145 93 7709 12.1 8.1
Duenas, Argentina, 2011 [52] NICU* 31270 139 8634 16.1 10.9
Becerra, Peru, 2010 [53] PICU* 3414 27 3420 7.9 6.5
Fernandez Jonusas, Argentina, 2011 [54] NICU* 31530 6 3157 1.9 0.4
Africa Rasslan , Egypt, 2012 [20] PICU* 3143 18 567 31.8 12.6
Rogers, South Africa, 2014 [55] Burn unit 292 41 - 30.0 40.2
El-Kholy, Egypt, 2012 [56] PICU* 1211 54 1478 36.5 25.6
El-Kholy, Egypt, 2012 [56] NICU* 1127 26 1003 25.9 20.5
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Table 3 Incidence densities and proportions of ventilator-associated pneumonia in pediatric settings (Continued)
Ben Jaballah, Tunisia, 2006 [57] PICU/NICU* 3340 7 1591 4.4 2.1
Badr, Egypt, 2011 [58] NICU* 256 32 315 101.6 57.1
El-Nawawy, Egypt, 2006 [59] PICU* - - - 10.9 -
Australia Gautam, Australia, 2012 [26] PICU* 2269 18 2564 7.0 6.7
*NICU: neonatal intensive care unit; PICU: pediatric intensive care unit; VAP: ventilator-associated pneumonia; VD: ventilation days.
**Proportion of patients with ventilator-associated pneumonia compared to patients included in the study (admissions or patients on ventilation).
1Patients on mechanical ventilation for 24 h or more.
2Patients on mechanical ventilation for more than 48 h.
3All admitted patients.
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tries reported significantly higher VAP rates in academic
compared to non-academic institutions [69]. VAP inci-
dence densities in an Iranian and Turkish NICU were
13.8/1000 and 11.6/1000 ventilator-days, respectively
[27,35]. A higher incidence was reported in another Iran-
ian study with 42% of 38 neonates on mechanical ventila-
tion [70]. Table 4 summarizes birth weight-dependent
numbers from different studies [8,21-23,42-44,49,71].
Several studies from the USA, Italy, and Iran found
that VAP prolonged mechanical ventilation by approxi-
mately 8–12 days [25,70,72,73], and this may even be as
high as 56 days in extremely preterm neonates [46]. Pro-
longed length of stay was the main driver of attributable
costs of up to US$ 1040 in Iran and US$ 51,157 in the
USA [70,73]. There are no data on the attributable mor-
tality of VAP. The mortality of HAI in the PICU is esti-
mated to range between 5-14% [27,44], to which VAP
may significantly contribute (P = 0.04) [25].Risk factors
Ventilation was the most important identified risk for
HAI in a prevalence study of 21 hospitals in Mexico (odds
ratio [OR], 2.3; 95% confidence interval [CI], 1.2-4.1) [74].
Reintubation (OR, 2.7; CI, 1.2-6.2) and transport out of
the PICU (OR, 8.9; CI, 3.8-20.7) were significant risk fac-
tors identified in a US PICU [74]. Other extrinsic risk
factors include prior antibiotic therapy (OR, 2.89; CI,
1.41-5.94), bronchoscopy (OR, 4.48; CI, 2.31-8.71), im-











≤ 750 g 2.5 2.6 11.8 2.4
751-1000 g 2.2 2.1 9.2 2.1
1001-1500 g 1.4 1.5 8.2 1.3
1501-2500 g 1.1 1.0 7.2 0.9
>2500 g 1.2 0.9 6.2 0.7
*Birth weight ≤1000 g.use of enteral feeding (OR, 8.78; CI, 2.13-36.20) [75-77]. A
number of intrinsic factors predisposing for VAP have been
reported, such as young age (<12 months) [75,78], subglottic
or tracheal stenosis (P = 0.02), trauma (P = 0.02), tracheos-
tomy (P = 0.04) [72], gastroesophageal reflux [79], immuno-
deficiency [28], neuromuscular blockade [28,75,80], genetic
syndromes (OR, 2.04; CI, 1.08-3.86) [46,76], and gender
(female: OR, 10.32; CI, 2.9-37.2) [77].
In neonates, the main risk factors are low birth weight
(hazard ratio [HR], 1.37; CI, 1.0-1.9]) and mechanical
ventilation (HR, 9.7; CI, 4.6-20.4) [8]. Time of mechan-
ical ventilation was a main factor in Spanish (OR, 1.1;
CI,1.1-1.2) [67], Chinese (OR, 4.8; CI, 2.2-10.4) [30], and
Iranian studies (P <0.001) [70]. Reintubation, absence of
tube feeding, and absence of stress ulcer prophylaxis
were risk factors in Australia [26]. In an Italian study,
reintubation (P < 0.001), tracheostomy (P = 0.04), and en-
teral feeding (P = 0.02) were associated with VAP [25].
Risk factors for VAP are summarized in Table 5.Microorganisms
The microorganism type and antibiotic susceptibility are
variable according to the geographical region (Figure 1).
Gram-negative pathogens predominate, but their contribu-
tion is exceptionally high in Asia. Overall, the most common
pathogens are Pseudomonas aeruginosa, Acinetobacter
baumannii, and Enterobacteriaceae. In Europe and North
America Staphylococcus aureus predominate [8,77,81]. In
Asia, most pathogens are multidrug-resistant [82-84]. A














3.5* 7.0* 19.7* 2.8* 2.3*
4.9 9.2 14.7 2.3 1.6
1.1 7.8 5.8 - -
0.9 8.3 7.4 - -
Table 5 Risk factors for ventilator-associated pneumonia in pediatric and neonatal settings
Risk factor Reference (Author, Ref No) Setting Patients VAP, n VAP, % Odds ratio [95% CI] P-value
Gender (female) Srinivasan [77] NICU/ PICU 60 19 32 10.3 [52.9-37.2] <0.001
Genetic syndromes Elward [46] PICU 595 34 5.1 2.4 [1.0-5.5] 0.043
Trauma Bigham [72] PICU 2846 42 1.47 - 0.020
Post-surgical admission diagnosis Srinivasan [77] NICU/ PICU 60 19 32 10.0 [2.2-46.1] 0.003
Subglottic or tracheal stenosis Bigham [72] PICU 2846 42 1.47 - 0.020
PRISM III score >10 Roeleveld [37] Cardiac surgery 125 11 8.8 4.4 [1.1-18.0] 0.041
Prolonged ventilation Awasthi [19] Ventilatory units 105 38 36.2 3.8 [1.4- 10.0] 0.008
Casado [51] PICU 366 39 10.7 1.0 [1.0-1.1] 0.017
Reintubation Patria [25] PICU 451 30 6.6 9.5 [3.3-26.8] <0.001
Elward [46] PICU 595 34 5.1 2.7 [1.2-6.2] 0.011
Tracheostomy Patria [25] PICU 451 30 6.6 4.4 [1.0-20.0] 0.040
Bigham [72] PICU 2846 42 1.47 - 0.040
Bronchoscopy Almuneef [28] PICU 361 37 10.3 5.0 [1.7-15.3] <0.001
Use of gastric tube Casado [51] PICU 366 39 10.7 2.9 [1.4-5.9] 0.003
Enteral feeding Patria [25] PICU 451 30 6.6 13.2 [1.5-114.2] 0.020
Srinivasan [77] NICU/PICU 60 19 32 8.8 [2.1- 36.2] 0.003
Almuneef [28] PICU 361 37 10.3 2.3 [1.1-4.8] 0.004
Prior antibiotic therapy Almuneef [28] PICU 361 37 10.3 2.5 [1.1-5.4] 0.026
Administration of blood products Srinivasan [77] NICU/PICU 60 19 32 0.1 [0.02- 0.6] 0.009
Use of sedatives/analgesics Srinivasan [77] NICU/PICU 60 19 32 77.5 [7.1- 844.6] <0.001
Casado [51] PICU 366 39 10.7 2.5 [1.3-4.7] 0.007
Neuromuscular blockade Da Silva [80] PICU 317 - 5 - 0.010
Transport out of the PICU* Elward [46] PICU 595 34 5.1 8.9 [3.8-20.7] <0.001
VAP: ventilator-associated pneumonia; PICU: pediatric intensive care unit.
*Transport out of the PICU for diagnostic procedures or medical interventions.
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ogens [85]. Isolates included Pseudomonas spp. (41.1%),
Acinetobacter spp. (39.7%), and Klebsiella spp. (19.2%).
Prevention
Many interventions in different combinations have been
shown to play a role in VAP prevention: hand hygiene,
preferably with alcohol-based handrub; glove and gown
use for endotracheal tube manipulation; backrest eleva-
tion of 30° to 45°; oral care with chlorhexidine; stress
ulcer prophylaxis; cuff pressure maintenance; use of oro-
gastric tubes; avoidance of gastric overdistension; and
elimination of nonessential tracheal suction [86]. Oral
care with chlorhexidine compared to placebo in 96 chil-
dren on mechanical ventilation was not effective in re-
ducing VAP in a Brazilian study [87]. Similar results
were reported in a placebo-controlled study with high
VAP rates in North India [88] and a randomized trial
among children undergoing cardiac surgery in Brazil
[89]. Gastroesophageal reflux is a constant incident in
mechanically- ventilated children, with alkaline reflux
more common than acidic reflux [79]. Thus, stress ulcerprophylaxis is rather unlikely to prevent VAP and, con-
sequently, neither sucralfate nor ranitidine were effective
in VAP prevention in a small study [90]. Two studies
showed that VAP rates are lower in neonates undergoing
nasal continuous positive airway pressure compared to
the use of mechanical ventilation [21,36].
A prevention bundle reduced VAP from 7.8/1000 to
0.5/1000 ventilator-days (P < 0.001) in a US PICU with
an estimated economy of 400 hospital-days and cost-
savings of US$ 2,353,222 [73]. In another PICU, a bun-
dle adapted to local needs by plan-do-study-act cycles
reduced VAP rates in a similar manner [72]. The bundle
addressed handling of ventilator circuits and oral suc-
tioning, hand hygiene, regular oral care with chlorhexi-
dine, and backrest elevation. By applying a multimodal
intervention, three PICUs reduced the incidence of
hospital-acquired pneumonia from 5.6 per 100 patients
at baseline to 1.9 in the intervention (P = 0.016) [91].
An educational program targeting resident physicians
and nurses in a PICU of a lower-middle-income country
resulted in a non-significant VAP reduction of 28% (P =
0.21) [92]. A quality improvement intervention targeting








Non-fermentative pathogens Gram-negative pathogens Gram-positive pathogens Other pathogens
Figure 1 Geographical distribution of pathogens causing ventilator-associated pneumonia in children.
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VAP from 28.3/1000 to 10.6/1000 ventilator-days (P =
0.005), which was sustainable over a long-term, follow-up
period [93]. In a before-after study in eight PICUs of five
developing countries, the efficacy of a multidimensional
infection control program including education, outcome
surveillance, process surveillance, and feedback on VAP
rates and performance reduced VAP from 11.7/1000 to
8.1/1000 ventilator-days (P = 0.02) [94]. The institution of
a purpose-designed bundle by a nurse-led VAP surveil-
lance program addressed backrest elevation; oral care
using chlorhexidine; clean suctioning practice; ranitidine
for all children not on full feeds; and four-hourly docu-
mentation [95]. After bundle implementation, no VAP was
recorded over a 12-month period. The baseline ventilator-
associated tracheobronchitis rate of 3.9/1000 ventilator-
days was reduced to 1.8/1000 (P = 0.04) by implementing a
multidisciplinary quality improvement initiative in another
US PICU [96].
A strategy combining care practices with empowering
the bedside nurse to lead bundle implementation in a
NICU encouraged personal ownership and compliance
with the bundle and finally reduced VAP by 31%, result-
ing in savings of 72 hospital-days and US$ 300,000 [97].The INICC multidimensional infection control program
was associated with significant reductions of VAP rates
in the NICUs of 15 cities from 10 developing countries
[98]. VAP rates at baseline and intervention were 17.8/
1000 and 12.0/1000 ventilator-days, respectively [98].
Of 491 patients receiving mechanical ventilation in a
Chinese NICU, the rate of VAP decreased from 48.8/1000
to 25.7/1000 ventilator-days and further diminished to
18.5/1000 after hospital relocation and establishing a bun-
dle of comprehensive preventive measures (P < 0.001) [99].
Conclusion
VAP is common in mechanically-ventilated children
with a wide variation of incidence density rates across
geographical regions. Surveillance definitions are chal-
lenging in pediatric settings because the combination of
clinical and radiologic signs leaves too much room for in-
terpretation. This is particularly important in neonates,
where CDC and INICC guidelines, and the German KISS
program follows mainly the rationale of the definitions for
older children. Gram-negative pathogens are the most
common microorganisms, particularly A. baumannii and
P. aeruginosa. However, there is a geographic variation
with Gram-positive organisms more frequently observed
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countries. Similar to the evidence base of adult settings, a
number of studies reported effective VAP prevention strat-
egies. Successful programs combined multiple interven-
tions, such as hand hygiene, glove and gown use for
endotracheal tube manipulation, backrest elevation, oral
care with chlorhexidine, stress ulcer prophylaxis, cuff
pressure maintenance where appropriate, use of orogastric
tubes, avoidance of gastric overdistension, and elimination
of nonessential tracheal suction. When applied as a multi-
modal strategy by an interdisciplinary team, these inter-
ventions are most likely to be successful among neonates,
infants, and children, and have proven effectiveness in
high-, as well as in low- and middle-income countries.
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